| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.13 | 0.003 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | 0.18 | 0.004 |
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | -0.094 | 0.004 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.005 |
| mRNA | lapatinib | FIMM | pan-cancer | AAC | 0.45 | 0.006 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.007 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.092 | 0.007 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.007 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.008 |